Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 27, 2010	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0001206774-10-001041.pdf 0001206774-10-001041.xls
Apr 12, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000021.pdf 0001237899-10-000021.xls
Mar 24, 2010	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001237899-10-000019.pdf 0001237899-10-000019.xls
Mar 24, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-10-000020.pdf 0001237899-10-000020.xls
Feb 19, 2010	8-K	Report of unscheduled material events or corporate event	View HTML 0001206774-10-000319.pdf 0001206774-10-000319.xls
Feb 19, 2010	4	Statement of changes in beneficial ownership of securities	View HTML 0001431092-10-000002.pdf 0001431092-10-000002.xls
Feb 18, 2010	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML 0001206774-10-000298.pdf 0001206774-10-000298.xls
Feb 16, 2010	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0000315066-10-002056.pdf
Feb 16, 2010	8-K	Report of unscheduled material events or corporate event	View HTML 0001206774-10-000283.pdf 0001206774-10-000283.xls
Feb 12, 2010	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000902219-10-000813.pdf 0000902219-10-000813.xls

Data provided by Kaleidoscope.

Investors & Media